Carroll PR - Search Results

1

Single-cell analysis of human primary prostate cancer reveals the heterogeneity of tumor-associated epithelial cell states.

Song H, Weinstein HNW, Allegakoen P, Wadsworth MH 2nd, Xie J, Yang H, Castro EA, Lu KL, Stohr BA, Feng FY, Carroll PR, Wang B, Cooperberg MR, Shalek AK, Huang FW. Song H, et al. Among authors: carroll pr. Nat Commun. 2022 Jan 10;13(1):141. doi: 10.1038/s41467-021-27322-4. Nat Commun. 2022. PMID: 35013146 Free PMC article.

2

Accelerated tumor proliferation rates in locally recurrent prostate cancer after radical prostatectomy.

Connolly JA, Presti JC Jr, Cher ML, Chew K, Shinohara K, Carroll PR. Connolly JA, et al. Among authors: carroll pr. J Urol. 1997 Aug;158(2):515-8. J Urol. 1997. PMID: 9224336

3

Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium.

Olumi AF, Grossfeld GD, Hayward SW, Carroll PR, Tlsty TD, Cunha GR. Olumi AF, et al. Among authors: carroll pr. Cancer Res. 1999 Oct 1;59(19):5002-11. doi: 10.1186/bcr138. Cancer Res. 1999. PMID: 10519415 Free PMC article.

4

Sextant prostate biopsies predict side and sextant site of extracapsular extension of prostate cancer.

Elliott SP, Shinohara K, Logan SL, Carroll PR. Elliott SP, et al. Among authors: carroll pr. J Urol. 2002 Jul;168(1):105-9. J Urol. 2002. PMID: 12050501

5

Contemporary trends in imaging test utilization for prostate cancer staging: data from the cancer of the prostate strategic urologic research endeavor.

Cooperberg MR, Lubeck DP, Grossfeld GD, Mehta SS, Carroll PR. Cooperberg MR, et al. Among authors: carroll pr. J Urol. 2002 Aug;168(2):491-5. J Urol. 2002. PMID: 12131295

6

Patterns of failure after primary local therapy for prostate cancer and rationale for secondary therapy.

Grossfeld GD, Li YP, P Lubeck DP, Carroll PR. Grossfeld GD, et al. Among authors: carroll pr. Urology. 2002 Sep;60(3 Suppl 1):57-62; discussion 62-3. doi: 10.1016/s0090-4295(02)01574-1. Urology. 2002. PMID: 12231051 Review.

7

Surgery for prostate cancer: rationale, technique and outcomes.

Downs TM, Kane CJ, Grossfeld GD, Meng MV, Carroll PR. Downs TM, et al. Among authors: carroll pr. Cancer Metastasis Rev. 2002;21(1):29-44. doi: 10.1023/a:1020164206406. Cancer Metastasis Rev. 2002. PMID: 12400995 Review.

8

Predicting recurrence after radical prostatectomy for patients with high risk prostate cancer.

Grossfeld GD, Latini DM, Lubeck DP, Mehta SS, Carroll PR. Grossfeld GD, et al. Among authors: carroll pr. J Urol. 2003 Jan;169(1):157-63. doi: 10.1016/S0022-5347(05)64058-X. J Urol. 2003. PMID: 12478126

9

How potent is potent? Evaluation of sexual function and bother in men who report potency after treatment for prostate cancer: data from CaPSURE.

Cooperberg MR, Koppie TM, Lubeck DP, Ye J, Grossfeld GD, Mehta SS, Carroll PR; CaPSURE. Cooperberg MR, et al. Among authors: carroll pr. Urology. 2003 Jan;61(1):190-6. doi: 10.1016/s0090-4295(02)02118-0. Urology. 2003. PMID: 12559294 Free article.

10

National practice patterns and time trends in androgen ablation for localized prostate cancer.

Cooperberg MR, Grossfeld GD, Lubeck DP, Carroll PR. Cooperberg MR, et al. Among authors: carroll pr. J Natl Cancer Inst. 2003 Jul 2;95(13):981-9. doi: 10.1093/jnci/95.13.981. J Natl Cancer Inst. 2003. PMID: 12837834 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

827 results

Search Page

Filters